VEGFA and diabetes mellitus: To date, the use of anti‐VEGF antibodies in diabetes has demonstrated the importance of maintaining a normal level of VEGF in the kidneys, as clinical studies have shown that complete elimination of VEGF can be detrimental and accelerate endothelial injury (Tao et al., 2021).